PL2585085T3 - Use of lactobacilli inhibiting gas producing coliform bacteria isolated from infants affected by colic - Google Patents

Use of lactobacilli inhibiting gas producing coliform bacteria isolated from infants affected by colic

Info

Publication number
PL2585085T3
PL2585085T3 PL10743216T PL10743216T PL2585085T3 PL 2585085 T3 PL2585085 T3 PL 2585085T3 PL 10743216 T PL10743216 T PL 10743216T PL 10743216 T PL10743216 T PL 10743216T PL 2585085 T3 PL2585085 T3 PL 2585085T3
Authority
PL
Poland
Prior art keywords
lactobacilli
colic
gas producing
coliform bacteria
bacteria isolated
Prior art date
Application number
PL10743216T
Other languages
Polish (pl)
Inventor
Gianna Scatizzi
Original Assignee
Probiotical Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Probiotical Spa filed Critical Probiotical Spa
Publication of PL2585085T3 publication Critical patent/PL2585085T3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/25—Lactobacillus plantarum
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Nutrition Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
PL10743216T 2010-06-28 2010-06-28 Use of lactobacilli inhibiting gas producing coliform bacteria isolated from infants affected by colic PL2585085T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP10743216.3A EP2585085B1 (en) 2010-06-28 2010-06-28 Use of lactobacilli inhibiting gas producing coliform bacteria isolated from infants affected by colic
PCT/IB2010/001554 WO2012001440A1 (en) 2010-06-28 2010-06-28 Use of lactobacilli inhibiting gas producing coliform bacteria isolated from infants affected by colic

Publications (1)

Publication Number Publication Date
PL2585085T3 true PL2585085T3 (en) 2014-10-31

Family

ID=42989661

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10743216T PL2585085T3 (en) 2010-06-28 2010-06-28 Use of lactobacilli inhibiting gas producing coliform bacteria isolated from infants affected by colic

Country Status (11)

Country Link
US (1) US9255246B2 (en)
EP (1) EP2585085B1 (en)
JP (1) JP2013531506A (en)
CN (1) CN103079580B (en)
BR (1) BR112012033212B1 (en)
DK (1) DK2585085T3 (en)
ES (1) ES2491619T3 (en)
PL (1) PL2585085T3 (en)
RU (1) RU2544054C2 (en)
UA (1) UA107711C2 (en)
WO (1) WO2012001440A1 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1403661B1 (en) 2011-01-28 2013-10-31 Probiotical Spa EFFERVESCENT COMPOSITION IN THE SOLID FORM FOR USE IN VAGINAL APPLICATIONS FOR THE TREATMENT OF VAGINAL INFECTIONS.
ITMI20110679A1 (en) * 2011-04-20 2012-10-21 Giovanni Mogna COMPOSITION INCLUDING PROBIOTIC BACTERES ABLE TO RESTORE THE BARRIER EFFECT OF THE STOMACH THAT IS LOST DURING THE PHARMACOLOGICAL TREATMENT OF GASTRICITY.
ITMI20110791A1 (en) 2011-05-09 2012-11-10 Probiotical Spa BACTERIA OF BACTERIA ABLE TO METABOLIZE THE OXALATES.
ITMI20110793A1 (en) 2011-05-09 2012-11-10 Probiotical Spa STRAINS OF PROBIOTIC BACTERIA AND SYNBIOTIC COMPOSITION CONTAINING THEMSELVES INTENDED FOR THE BABY FOOD.
ITMI20110792A1 (en) 2011-05-09 2012-11-10 Probiotical Spa STRAINS OF BACTERIA BELONGING TO THE BIFIDOBACTERIUM TYPE FOR USE IN THE TREATMENT OF HYPERCOLESTEROLEMIA.
ITRM20110477A1 (en) 2011-09-09 2013-03-10 Giovanni Mogna COMPOSITION INCLUDING N-ACETYLCISTEIN AND / OR LYSOZYME MICROINCAPSULATE GASTROPROTECT IN ASSOCIATION WITH PROBIOTIC BACTERES ABLE TO RESTORE THE BARRIER EFFECT OF THE STOMACH THAT IS LOST DURING THE PHARMACOLOGICAL TREATMENT OF
ITRM20110475A1 (en) * 2011-09-09 2013-03-10 Probiotical Spa BACTERIA OF LACTIC AND / OR BIFIED BACTERIA BACTERIA, OPTIONALLY ADDED TO N-ACETYLCISTEIN AND / OR LYSOZYME MICROINCAPSULATE GASTROPROTETTO, HAVING INHIBITION ACTIVITIES / REDUCTION OF THE GROWTH OF DIFFERENT E.COLI BIOTYPES, INCLUDING E.COLI O157: H7 E
ITMI20111718A1 (en) 2011-09-23 2013-03-24 Probiotical Spa A WATERPROOF MOISTURE AND OXYGEN MATERIAL FOR PACKAGING DIETARY, COSMETIC AND MEDICINAL PRODUCTS.
US11179427B2 (en) 2013-01-21 2021-11-23 Eth Zurich Baby food composition comprising viable propionic acid-producing bacteria
ITMI20130793A1 (en) 2013-05-14 2014-11-15 Probiotical Spa COMPOSITION INCLUDING LACTIC BACTERIA FOR USE IN THE PREVENTIVE AND / OR CURATIVE TREATMENT OF THE RECURRENT CYCLES.
CN106459876A (en) * 2014-03-28 2017-02-22 促接合因子股份有限公司 Preparation of small colony variants of therapeutic bacteria
EP3294308A4 (en) 2015-05-14 2019-03-06 University of Puerto Rico Methods for restoring microbiota of newborns
JP6245487B2 (en) * 2015-08-12 2017-12-13 ヤヱガキ醗酵技研株式会社 Information processing apparatus, information processing method, and program
US11564667B2 (en) 2015-12-28 2023-01-31 New York University Device and method of restoring microbiota of newborns
PE20190122A1 (en) * 2016-02-12 2019-01-17 Probiotical Spa USE OF BACTERIAL STRAINS BELONGING TO THE LACTOBACILLUS KEFIRI SPECIES IN PEDIATRICS TO GENERATE AND / OR MAINTAIN A STATE OF HOMEOSTASIS
ITUB20160708A1 (en) * 2016-02-12 2017-08-12 Probiotical Spa Use of strains of bacteria belonging to the Lactobacillus kefiri species in pediatrics to generate and / or maintain the state of homeostasis.
KR102135195B1 (en) * 2018-10-08 2020-07-17 아주대학교산학협력단 Composition for preventing or treating behcet's diseases or herpes simplex virus infection containing tetragenococcus halophilus
CN113142396A (en) * 2021-06-11 2021-07-23 中国农业大学 Microbial inoculum for preparing leguminous forage silage

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040161422A1 (en) 1999-04-30 2004-08-19 Natarajan Ranganathan Nutritional compositions comprising probiotics
ITMI20020399A1 (en) * 2002-02-28 2003-08-28 Ct Sperimentale Del Latte S P DIETARY AND / OR PHARMACEUTICAL COMPOSITIONS FOR HUMAN AND / OR ANIMAL USE BASED ON MICROBIAL PROBIOTIC PREPARATIONS
JP2006501281A (en) * 2002-09-26 2006-01-12 プロバイオヘルス・エルエルシー Prebiotic and conservative use of oil emulsified probiotic capsules
US20040185032A1 (en) * 2003-03-18 2004-09-23 David Burrell Compositions and methods for treating colic
JP4387972B2 (en) * 2005-04-14 2009-12-24 大洋香料株式会社 Antioxidant
RU2391393C1 (en) 2008-11-19 2010-06-10 Галина Геннадиевна Алехина Lactobacillus delbrueckii TS1-06 STRAIN USED FOR MAKING BACTERIAL PREPARATIONS AND PRODUCTION OF LIQUID SOUR MILK BROTH AS FOOD PRODUCT FOR MEDICAL AND PREVENTIVE PURPOSES

Also Published As

Publication number Publication date
CN103079580A (en) 2013-05-01
WO2012001440A1 (en) 2012-01-05
RU2544054C2 (en) 2015-03-10
JP2013531506A (en) 2013-08-08
US9255246B2 (en) 2016-02-09
UA107711C2 (en) 2015-02-10
BR112012033212A2 (en) 2016-10-25
BR112012033212B1 (en) 2021-06-08
EP2585085A1 (en) 2013-05-01
US20130195823A1 (en) 2013-08-01
ES2491619T3 (en) 2014-09-08
EP2585085B1 (en) 2014-05-28
DK2585085T3 (en) 2014-06-23
RU2013102424A (en) 2014-08-10
CN103079580B (en) 2015-04-29

Similar Documents

Publication Publication Date Title
PL2585085T3 (en) Use of lactobacilli inhibiting gas producing coliform bacteria isolated from infants affected by colic
HK1244725A1 (en) Methods for ozone sanitization of continuous positive airway pressure devices
ZA201304280B (en) Treatment of jak2-mediated conditions
PL2425721T3 (en) Process for the purification of high-purity mogrosides
ZA201301601B (en) Treatment of diseases
EP2613786A4 (en) Treatment of diseases
GB0915515D0 (en) Treatment of vasculoproliferative conditions
IL206491A0 (en) Treatment of produce
PT2554932E (en) Tube reactor for thermal treatment of biomass
IL214745A0 (en) Treatment of insulin-resistant disorders
ZA201208672B (en) Process for the preparation of synthesis gas
PT2681158T (en) Treatment of raw brines from desalination plants
EP2501227A4 (en) Treatment of ophthalmic conditions with fluorenone derivatives
ZA201102173B (en) Treatment of water
ZA201202514B (en) Use of cyclic keto-enols for combating plant pathogenic bacteria
HK1223334A1 (en) Process for the manufacture of implants or intermediate products of such implants as well as implants and intermediate products obtained by such process
EP2473519A4 (en) Treatment of diseases caused by bacterial exotoxins
EP2529752A4 (en) Use for production of therapeutic agent or prophylactic agent for osteoarthritis
EP2603531A4 (en) Chlorine dioxide treatment of biomass feedstock
HK1181258A1 (en) Process for the preparation of disinfected human cell suspensions
IL215100A0 (en) Improved chemical synthesis of diazaindoles by chichibabin cyclization
EP2440238A4 (en) Methods of treatment
GB201017469D0 (en) Fitting of bed sheets
IL200248A0 (en) Ring for memorizing times of baby nursing
GB201000195D0 (en) Concentration of bacteria